Pharmaceutical Schedule definition

Pharmaceutical Schedule means the pharmaceutical schedule produced by PHARMAC pursuant to section 48(a) of the New Zealand Public Health and Disability Act 2000;
Sample 1Sample 2Sample 3
Pharmaceutical Schedule means the list of the prescription medicines and therapeutic products subsidised by the Crown (http://www.pharmac.govt.nz/Schedule).
Sample 1Sample 2
Pharmaceutical Schedule means the pharmaceutical schedule produced by PHARMAC. Pharmaceutical Schedule Pack Subsidy means the subsidy specified in the Pharmaceutical Schedule at which a pack of the relevant Pharmaceutical is subsidised (excluding GST). Pharmaceutical Schedule Rule on Close Control means the Close Control rule described in the Pharmaceutical Schedule (NB It is planned for this rule to be replaced with the ‘Dispensing Frequency Rule’). Pharmaceutical Schedule Rule on Frequency of Dispensing means the Frequency of Dispensing Rule described in the Pharmaceutical Schedule. Pharmaceutical Transactions Data Specification means the publication entitled the “Pharmaceutical Transaction Data Specification”, as amended by us from time to time following Consultation with you. Pharmacist means a person for the time being registered as a pharmacist with the Pharmacy Council and who holds a current annual practising certificate under the HPCA Act. Pharmacy means a place of business that is licensed under the Medicines Act. Pharmacy Charges has the meaning given to it in clause H4.6.
Sample 1Sample 2

Examples of Pharmaceutical Schedule in a sentence

  • D7.1 We will, through PHARMAC, make available to you the Pharmaceutical Schedule.

  • The Pharmaceutical Schedule sets out the terms and conditions under which pharmaceuticals are supplied to patients and practitioners.

  • You agree to comply with the terms and conditions of the Pharmaceutical Schedule.

  • Pharmaceutical Schedule The current Pharmaceutical Schedule as published by PHARMAC from time to time, being a list of pharmaceuticals that are subsidised by the Government and stating the amount of the subsidy paid.

  • You acknowledge that the Pharmaceutical Schedule may be varied from time to time by PHARMAC.

  • If you have a particular concern regarding any change to the Pharmaceutical Schedule, you may notify us in writing of your concern and we will then use our reasonable endeavours to address it with PHARMAC, which may entail discussion(s), meeting(s) or correspondence with PHARMAC, as appropriate.

  • PHARMAC would need to follow the provisions for all formal applications seeking listing and reimbursement (subsidisation) on its Pharmaceutical Schedule.

  • Dispensing will comply with the Pharmaceutical Schedule, all legislation and regulations applicable to the practice of Pharmacy in New Zealand, the Health and disability services Standards – Pharmacy services Standard NZS 8134.7:2010, the Code of Ethics and any other professional requirements which may be specified by the Pharmacy Council.

  • We will, through PHARMAC make available to you, free of charge, a total of one hard copy per Premises of the Pharmaceutical Schedule.

  • You must only Dispense on the receipt of Prescription Forms that are written in accordance with current legislation and meet the requirements for subsidy and payment in the current Pharmaceutical Schedule and as set out in the Procedures Manual.


More Definitions of Pharmaceutical Schedule

Pharmaceutical Schedule means the pharmaceutical schedule produced by Pharmac pursuant to section 62(1)(a) of the Pae Ora (Healthy Futures) Act 2022;
Sample 1Sample 2
Pharmaceutical Schedule means the schedule listing all the medicines funded for New Zealanders (as updated from time to time); Price means the price (exclusive of GST) of the Pharmaceutical recorded in Annex 1; Supply Issue means an event which may result, or has resulted, in a failure to supply the Pharmaceutical in accordance with this Agreement, including but not limited to:
Sample 1Sample 2

Related to Pharmaceutical Schedule

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • Active Pharmaceutical Ingredient or “API” shall mean one or more of the following active pharmaceutical ingredients: tenofovir alafenamide (“TAF”), tenofovir disoproxil fumarate (“TDF”), elvitegravir (“EVG”), and cobicistat (“COBI”).

  • Pharmaceutical care means the provision of drug therapy and

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Radiopharmaceutical service means, but is not limited to, the procurement, storage, handling preparation, labeling, quality assurance testing, dispensing, delivery, recordkeeping, and disposal of radiopharmaceuticals and other drugs.

  • Pharmaceutical means any compound or mixture, other than food, used in the prevention, diagnosis, alleviation, treatment, or cure of disease in human and animal.

  • Radiopharmaceutical means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any non-radioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance, but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Development Schedule shall have the meaning set forth in Section 1.1.

  • Existing Products Tangible Products and intangible licensed Products which exist prior to the commencement of work under the Contract. Contractor retains the burden of proving that a particular product was existing before commencement of the Project. .

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • New Products means any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Drug outlet means a pharmacy, nursing home, shelter home, convalescent home, extended care facility, drug abuse treatment center, penal institution, hospital, family planning clinic, student health center, retail store, wholesaler, manufacturer, mail-order vendor or other establishment with facilities located within or out of this state that is engaged in dispensing, delivery or distribution of drugs within this state.

  • Formulation means the combination of various ingredients designed to render the product useful and effective for the purpose claimed, or the form of pesticide as purchased by users;

  • Existing Product means any formulation of the same product category and form sold, supplied, manufactured, or offered for sale in California prior to the following dates, or any subsequently introduced identical formulation:

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Manufacturing Process means any process for—

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Additional Products means products, services and applications that are not part of the Services but that may be accessible, via the Admin Console or otherwise, for use with the Services.

  • API means American Petroleum Institute.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Tobacco product manufacturer means an entity that after the date of enactment of this Act directly (and not exclusively through any affiliate):

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.